Veriheal

DECEMBER 30, 2020

If you answered yes to these two questions, then the DEA might have the job for you. The DEA is seeking a contractor that has the ability to destroy illegal drugs without leaving detectable levels behind. ” The tricky thing about this is that not very many places use incinerators. What about the bird’s man?

DEA 52

DEA Pharmaceutical Packaging Business 52

Veriheal

DECEMBER 19, 2023

A new delta-8 study has revealed that people in states without access to legal cannabis products are far more likely to seek out and consume delta-8 and delta-9 variants, whether it be flower, edibles, or tinctures. To learn more about your access to medical cannabis or legal products, talk to one of our doctors today.

Legalization 111

Legalization Edibles DEA Access 111

Veriheal

DECEMBER 27, 2022

Let’s dive into what the research says about these promising new findings and how they might advance the field of psychedelic research. The participants completed a survey asking about lifetime experiences with: Psychedelics (LSD, psilocybin, DMT, mescaline). What Are Psychedelics? Methamphetamine. Amphetamine. The Bottom Line.

Research and Development 95

Research and Development Therapy Consumption DEA 95

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. “Patients will benefit from cGMP-quality therapies in an accessible and efficient format.”. . Most recently the FDA awarded MMJ International Holdings ? .

DEA 66

DEA Clinical Trials THC Research and Development 66

Cannabis Law Report

MAY 10, 2022

Activists staged a demonstration outside of the Drug Enforcement Administration (DEA) headquarters in Virginia on Monday, demanding that the agency allow terminally ill patients to access psilocybin therapy. Marijuana Moment reports. DeaOutoftheway @RTTpsilocybin pic.twitter.com/1NJWt2cJWn. aeidinger) May 9, 2022.

DEA 52

DEA Therapy Access Patients 52

Cannabis Law Report

MARCH 30, 2022

NORML has long advocated for amending federal regulations so that federally-licensed scientists can directly access and assess the wide variety of cannabis products readily available in medical-use and adult-use state markets. The full text of S. 253 is online here. Additional information is available from NORML here.

Legislation 95

Legislation Clinical Trials DEA Access 95

Veriheal

MARCH 6, 2024

Department of Health and Human Services (HHS) recommended that the Drug Enforcement Agency (DEA) reshedule cannabis as a Schedule III substance in August of 2023. As it currently stands, the Controlled Substance Act makes it incredibly difficult for the DEA and outside research groups to grow cannabis products for the purpose of research.

Research and Development 62

Research and Development DEA Chronic Pain Business 62

Canna Law Blog

AUGUST 16, 2022

As a refresher, the Drug Enforcement Administration (DEA) conducts the licensing process that enables researchers to gain access to cannabis product. The DEA still views cannabis as a controlled substance with “no known medical uses.” See: Not All Cannabis Reform is a Good Thing.).

DEA 66

DEA Access Cannabinoids Cannabis 66

Cannabis Law Report

SEPTEMBER 23, 2021

The notice lists five “Things to Know” about the serious health risks of delta-8 THC: Delta-8 THC products have not been evaluated or approved by the FDA for safe use and may be marketed in ways that put the public health at risk. Delta-8 THC products should be kept out of the reach of children and pets. Should be stored away from children.

THC 52

THC Concentrates Pets DEA 52

Cannabis Law Report

MARCH 7, 2020

In its performance budget submission to Congress for fiscal year 2021, DEA gave an overview of its enforcement efforts and made predictions about future trends. DEA Admits State-Level Marijuana Legalization Reduces Illegal Market Demand. The acknowledgement seems to be two-parted. dea_cj_fy_2021_03062020.

DEA 64

DEA THC Retail Access 64

Cannabis Law Report

JULY 7, 2021

Pennington, who focuses on federal appeals and regulatory issues, is co-counsel on several high-profile cases against the DEA regarding cannabis research, hemp, and psychedelics. Circuit), a pending petition for review of DEA’s August 2020 Interim Final Rule purportedly implementing the 2018 Farm Bill’s amendments to the CSA.

DEA 111

DEA Hemp Cultivation Advocacy 111

Veriheal

APRIL 11, 2022

We know that the plant has powerful potential medical effects, but it clearly needs more refinement, more research and more data,” stated Groff, who envisions a future where patients can easily access ailment-targeted cannabis meds. Drug Enforcement Agency (DEA). This means that U.S. The post New U.S.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

JULY 20, 2021

Prospective investors are invited to access the offering, which has raised over $2.2 ABOUT GOOD EARTH ORGANICS. ABOUT SEEDINVEST. SeedInvest is a leading equity crowdfunding platform that provides individual investors with access to vetted startup investment opportunities. Investor Relations: Scott Morrison.

DEA 98

DEA Cultivation Access Hemp 98

Veriheal

JUNE 30, 2023

What do you think about psilocybin’s potential to help those with alcohol addiction? Lastly, the guide lays out the complex DEA registration process researchers much navigate to gain access to plants like psilocybin. Let us know in the comments!

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Cannabis Law Report

FEBRUARY 8, 2022

A new Colorado law aimed at keeping young people from buying and reselling highly potent THC concentrate has sparked concerns from doctors who recommend medical cannabis about how the new provisions could jeopardize their ability to practice medicine. 2021a_1317_signed.

Patients 52

Patients Legislation Concentrates DEA 52

Cannabis Law Report

MAY 29, 2022

8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. DEA and the Controlled Substances Act. In addition to the arduous FDA approval process, potential psychedelic therapies would also require complying with requirements from the Drug Enforcement Administration (DEA). Times (Nov.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

DECEMBER 15, 2021

The importation of the naturally derived psilocybin into California was completed after the Company’s supply partner Mycrodose Therapeutics was granted an import license from the United States Drug Enforcement Administration (DEA). “Having a supply partner that gives us access to the rapidly growing U.S.

Supply Chain 52

Supply Chain Research and Development DEA Pharmaceutical 52

SpeedWeed

JULY 13, 2021

Benjamin Wann, a cannabis patient, and his parents, Amber and Brad, supported Polis back in May when he signed the law that expanded access to cannabis in schools. He doesn’t have a wheelchair,” Amber said about her son. “He He understands exactly what’s going on, and it’s not just about him. He does have a voice.

Law 52

Law Patients DEA Access 52

Canna Law Blog

JULY 14, 2023

You can access the letters here. But, there’s a huge controversy about whether it can be controlled, with agencies like the DEA saying it is. You can read more about that issue here or here. Indeed, the FDA maintains a web page warning about the supposed dangers of delta-8 products.

Packaging 74

Packaging Food Edibles THC 74

Veriheal

NOVEMBER 11, 2023

According to the United States Drug Enforcement Administration (DEA), Schedule One drugs are “drugs with no currently accepted medical use and a high potential for abuse.” 5520), and the Veterans Equal Access Act (H.R. However, it is clear that there is momentum to give veterans access to cannabis.

Law 62

Law Chronic Pain Conditions Legislation 62

Veriheal

DECEMBER 1, 2020

When many people think about cannabis, they think about THC and CBD. The DEA is Already Interfering. In August of this year, little to most people’s knowledge, the DEA continued their draconian stance against cannabis by proposing that THC derivatives also be classified as schedule one controlled substances.

THC 52

THC DEA Research and Development Cannabinoids 52

The Blunt Truth

DECEMBER 29, 2023

As of now, this is still a proposal, and it’s anyone’s guess if the DEA (who would do the actual re-scheduling) will think that’s a good idea. But what about federal legislation ?? The only state in the country where this is permitted, the thought was to allow patients in rural areas of the state access to cannabis.

DEA 52

DEA Retail Legalization Food 52

Canna Law Blog

DECEMBER 6, 2022

As we blogged about last week, the SAFE Banking Act is trying to claw its way back from the dead during this lame duck session of Congress. Unless you’ve been living under a rock, you know that two of the biggest problems for the cannabis industry overall are access to financial institutions and I.R.C. Section 280E.

Banking 81

Banking Compliance Compliance State Laws 81

Cannabis Law Report

AUGUST 12, 2022

Marijuana Moment report on some of the panels being proposed for 2023…… Voting is now open for the public to decide which panels will make the stage at next year’s South By Southwest (SXSW) festival—and there are about 100 marijuana- and psychedelics-related proposals to pick from. Which Political Party Will Legalize Weed?

Research and Development 52

Research and Development Events Topical Policy 52

Veriheal

AUGUST 24, 2022

According to The Denver Post , Melanie Rose Rodgers—a prominent activist who helped get psilocybin decriminalized in Denver in 2019—has cited concerns about a corporate takeover of natural medicine following the enactment of Initiative 58. They won’t care about what you say until they know how much you care.”.

Legalization 108

Legalization Medicine Decriminalization Research and Development 108

Cannabis Law Report

JUNE 11, 2021

Cannabis faces an overall lack of access to financial institutions as well as IRC 280E, and ketamine certainly does not. That’s about it though. Cannabis is not regulated by the Food and Drug Administration and federal healthcare laws generally don’t apply to state-licensed cannabis businesses. This answer depends on state law.

Law 104

Law Compliance Compliance DEA 104

MedicalJane

JUNE 29, 2018

Marketing unapproved products, with uncertain dosages and formulations can keep patients from accessing appropriate, recognized therapies to treat serious and even fatal diseases.”. The Next Move Is On The DEA. Epidiolex’s launch is in the hands of the DEA. Insurance coverage could well be the deciding factor.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

Canna Care Docs

SEPTEMBER 26, 2019

About Canna Care Docs…. Powered by Sail, we are on a mission to solve the issue of cannabis access for patients. We’re passionate about improving our patient’s quality of life and bringing cannabis into mainstream healthcare. WE ARE SEEKING LICENSED MD OR ARPNs for our Hartford, CT clinic.

History 40

History DEA Therapy Patients 40

SpeedWeed

AUGUST 16, 2021

Lepp’s wife, Sandra Castaneda, posted on Facebook about the tragic news on August 16. Lepp was one of the industry’s greatest advocates, leaving his mark as one of many who suffered in prison as a result of trying to cultivate medical cannabis and help patients get access.

DEA 52

DEA Patients Therapy Cannabis 52

Cannabis Law Report

JANUARY 16, 2020

Lawmakers have to come back, perhaps not having thought seriously about what that means, and build a law around this vague idea the people have supported.” . One of the great things about the United States is that each state has its own system for dealing with this issue and it makes for a giant experiment.

Law 59

Law Legalization DEA Marijuana 59

Cannabis Law Report

JUNE 16, 2021

Arizona, Colorado, Delaware, and Montana are among the states that have explicitly banned sales of Delta-8 and at least four other states have already removed it from the shelves or otherwise restricted market access. A full 20% of Delta-8 consumers do not use Delta-9 THC, which points to something unique about Delta-8.

THC 117

THC Hemp Media Data 117

Cannabis Law Report

APRIL 21, 2022

Publication of this process establishes “prior art,” contributing to MAPS’ patient access strategy by making intellectual property public . ABOUT MAPS . ABOUT MAPS PUBLIC BENEFIT CORPORATION (MAPS PBC) . 30,000 patient doses) of MDMA in a four-step process beginning with a non-controlled starting material. MEDIA CONTACT .

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

Cannabis Law Report

JANUARY 23, 2020

” Here’s some information about what’s contained in the free report. It was called the “Cuban cigar of the marijuana world” by a DEA agent in 1967 and even compared with French wine. This is not least due to its exceptional cultivation conditions and central position within the Southeast Asian trading zone.

Research and Development 59

Research and Development Oil Cultivation DEA 59

SpeedWeed

AUGUST 19, 2021

In recent months, a synthetic compound derived from hemp called THC-O acetate—often referred to simply as THC-O (pronounced “THC oh”)—has quickly gained popularity among Americans who don’t have access to legal cannabis. . THC-O products are increasingly popular in states where consumers don’t have access to legal cannabis.

THC 52

THC Hemp Extraction Vaping 52

CannaMD

SEPTEMBER 15, 2020

Thinking about getting your card? What about travel? MORE DETAILS: On June 16, 2014, Florida became the 22nd state to legalize (at least partial) access to medical marijuana when Governor Rick Scott signed the Compassionate Medical Cannabis Act of 2014. To learn more about the CannaMD team, see: Meet Our Doctors.

Law 126

Law Marijuana Patients Treatment 126

Canna Law Blog

JANUARY 11, 2022

The thought process goes that three things will reduce the illicit market: (1) federal and statewide legalization, (2) incentives to access the legal market, and (3) putting compliance ahead of enforcement. There are really two big buckets of potential issues here: First, let’s talk about licensees that break rules.

Compliance 78

Compliance Compliance State Laws DEA 78

Canna Law Blog

NOVEMBER 20, 2020

As we’ve written about before , bankruptcy hasn’t been a viable option for cannabis businesses, including ancillary businesses that derive any portion of their revenue from cannabis. The remaining assets will be distributed to the remaining creditors in line of priority.

Hemp 55

Hemp Business DEA Banking 55